Perfusion MRI Services
Medwave offers specialised post-processing services for perfusion MRI (pMRI), providing derived prognostic biomarkers for both clinical trial and routine clinical applications. Our platform delivers parametric maps and ROI statistics with fast turnaround times.
"Parametric maps from pMRI serve as additional progression parameters to differentiate between pseudo-progression and true-progression, a critical distinction in oncology trials evaluating immunotherapy and targeted therapies."
Clinical Trial Applications
Pseudo-progression
Parametric maps used as additional parameters to differentiate pseudo-progression from true tumour progression.
Biomarker Endpoints
pMRI-derived biomarkers incorporated as response parameters in modified assessment criteria such as RANO.
Integrated Workflows
Post-processing integrated with central review, ensuring parametric data feeds directly into endpoint analysis.
Clinical Routine
1 Workday Turnaround
Report delivery with parametric maps and ROI statistics within 1 workday upon receipt via the imaging portal.
Customisable Reporting
Reports tailored to institutional needs, including parametric maps, ROI statistics, and clinical context.
Remote Radiology Support
Board-certified radiologists available for staffing solutions and routine clinical review support.